Time to pregnancy after a prepregnancy very-low-energy diet program in women with obesity: substudy of a randomized controlled trial.


Journal

Fertility and sterility
ISSN: 1556-5653
Titre abrégé: Fertil Steril
Pays: United States
ID NLM: 0372772

Informations de publication

Date de publication:
12 2020
Historique:
received: 23 03 2020
revised: 22 06 2020
accepted: 23 06 2020
pubmed: 21 10 2020
medline: 25 5 2021
entrez: 20 10 2020
Statut: ppublish

Résumé

To examine the impact of a prepregnancy very-low-energy diet (VLED) program on time to pregnancy in women with obesity. Substudy of a two-arm parallel group randomized controlled trial. Multiple tertiary care centers. Women 18-38 years old with obesity (body mass index 30-55 kg/m One hundred sixty-four normoglycemic women with body mass index 30-55 kg/m The prespecified exploratory outcome for this substudy was time to pregnancy between the completion of the 12-week intervention and the date of conception. Maternal weight loss at the end of the 12-week intervention was 3.1% in the SDI group and 11.9% in the VLED group. In completers of the 12-week intervention, time to pregnancy was significantly shorter in the women allocated to the VLED group than in the SDI group. Post hoc analysis showed that this difference in time to conception was particularly overt within 90 days of the intervention. A VLED program that achieves substantial weight loss before conception reduces time to pregnancy compared with an SDI in women with obesity. ACTRN12614001160628.

Identifiants

pubmed: 33077241
pii: S0015-0282(20)30604-X
doi: 10.1016/j.fertnstert.2020.06.033
pii:
doi:

Banques de données

ANZCTR
['ACTRN12614001160628']

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1256-1262

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Auteurs

Sarah A Price (SA)

Department of Medicine (Austin), University of Melbourne, Melbourne, Victoria, Australia; Department of Endocrinology, Austin Health, Melbourne, Victoria, Australia; Department of Diabetes and Endocrinology, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Department of Obstetrics and Gynaecology, Mercy Hospital for Women, Melbourne, Victoria, Australia; Department of Obstetrics and Gynaecology, Royal Women's Hospital, Melbourne, Victoria, Australia. Electronic address: Sarah.price@unimelb.edu.au.

Priya Sumithran (P)

Department of Medicine (Austin), University of Melbourne, Melbourne, Victoria, Australia; Department of Endocrinology, Austin Health, Melbourne, Victoria, Australia.

Luke A Prendergast (LA)

Department of Mathematics and Statistics, La Trobe University, Melbourne, Victoria, Australia.

Alison J Nankervis (AJ)

Department of Diabetes and Endocrinology, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Department of Obstetrics and Gynaecology, Royal Women's Hospital, Melbourne, Victoria, Australia.

Michael Permezel (M)

Department of Obstetrics and Gynaecology, Mercy Hospital for Women, Melbourne, Victoria, Australia.

Joseph Proietto (J)

Department of Medicine (Austin), University of Melbourne, Melbourne, Victoria, Australia; Department of Endocrinology, Austin Health, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH